Vimarsana
Biggest News Aggregation in the World

Page 37 - Looking Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Looking Statement Today - Breaking & Trending Today

Merck's WELIREG® (belzutifan) Significantly Improved Progression-Free Survival and Objective Response Rates Versus Everolimus in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) -October 21, 2023 at 08:46 am EDT - Vimarsana News

Merck's WELIREG® (belzutifan) Significantly Improved Progression-Free Survival and Objective Response Rates Versus Everolimus in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC) -October 21, 2023 at 08:46 am EDT

Published: October 21, 2023

At a pre-specified interim analysis in LITESPARK-005, WELIREG reduced the risk of disease progression or death compared to everolimus First Phase 3 trial to show positive results in patients with...

Source: marketscreener.com
Related Topics:
United StatesMerck Co IncExchange CommissionStatement Of Merck Co IncEuropean Society For Medical OncologyEuropean SocietyMedical OncologySafety InformationEmbryo Fetal ToxicityReproductive PotentialLooking StatementSecurities Litigation Reform ActAnnual Report
KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Progression-Free Survival (PFS) Versus Trastuzumab and Chemotherapy in First-Line HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma - Vimarsana News

KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Progression-Free Survival (PFS) Versus Trastuzumab and Chemotherapy in First-Line HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Published: October 20, 2023

In the KEYNOTE-811 trial, the KEYTRUDA regimen demonstrated a statistically significant PFS improvement in advanced HER2-positive gastric or GEJ adenocarcinoma in tumors expressing PD-L1 compared to...

Source: marketscreener.com
Related Topics:
United StatesYelenay JanjigianMerck Co IncEuropean CommissionExchange CommissionDrug AdministrationMemorial Sloan Kettering Cancer CenterStatement Of Merck Co IncEuropean Society For Medical OncologyMerck Research LaboratoriesEuropean SocietyMedical OncologyCombined Positive ScoreChief Attending PhysicianGastrointestinal OncologyPrincipal InvestigatorMarjorie GreenMerck ResearchNeck Squamous CellBacillus Calmette GuerinMismatch Repair DeficientMismatch Repair Deficient ColorectalImportant Safety InformationFatal Immune Mediated AdverseWhich Can Present With Diabetic
Kodiak Copper Drills Significant From-Surface Copper at West Zone: 0.58% CuEq Over 254 m within 0.27% CuEq over 941 m - Vimarsana News

Kodiak Copper Drills Significant From-Surface Copper at West Zone: 0.58% CuEq Over 254 m within 0.27% CuEq over 941 m

Published: October 17, 2023

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Source: juniorminingnetwork.com
Related Topics:
British ColumbiaUnited StatesUnited KingdomCopper MountainNorth VancouverGreat BearClaudia TornquistJohn RobinsChris TaylorJeff WardKodiak Copper CorpVenture ExchangeCompany Or KodiakJunior Mining NetworkCanada LtdDiscovery GroupNational InstrumentVp Corporate DevelopmentInternational StandardsRegulation Services ProviderBritish Columbia Newsfile CorpWest ZoneRed ChrisGate ZoneTarget Location Map
Kodiak Drills Significant From-Surface Copper at West Zone: 0.58% CuEq Over 254 m within 0.27% CuEq over 941 m -October 17, 2023 at 06:05 am EDT - Vimarsana News

Kodiak Drills Significant From-Surface Copper at West Zone: 0.58% CuEq Over 254 m within 0.27% CuEq over 941 m -October 17, 2023 at 06:05 am EDT

Published: October 17, 2023

Kodiak Copper Corp. today reports results from its fully funded drill program at its 100% owned MPD copper-gold porphyry project in southern British Columbia. Assay results from five drill holes...

Source: marketscreener.com
Related Topics:
British ColumbiaNorth VancouverCopper MountainGreat BearUnited StatesUnited KingdomJohn RobinsClaudia TornquistChris TaylorJeff WardInternational StandardsDiscovery GroupVp Corporate DevelopmentKodiak Copper CorpCompany Or KodiakVenture ExchangeCanada LtdNational InstrumentBritish Columbia Newsfile CorpRegulation Services ProviderWest ZoneRed ChrisGate ZoneTarget Location MapZone Drill Results
Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease - Vimarsana News

Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease

Published: October 17, 2023

RAHWAY, N.J.--(BUSINESS WIRE)--Oct 17, 2023--

Source: eagletribune.com
Related Topics:
United StatesPeter DannenbaumElizabeth RheeSteven GrazianoJulie CunninghamDeb WamboldEuropean CommissionEuropean Medicines AgencyExchange CommissionMerck Research LaboratoriesStatement Of Merck Co IncCommittee For Medicinal Products Human UseEuropean UnionDrug AdministrationMerck Co IncAicuris Gmbh CoMedicinal ProductsHuman UseMerck ResearchSafety InformationPrescribing InformationAicuris GmbhLooking StatementSecurities Litigation Reform ActAnnual Report